Zohar Krivorot

Zohar Krivorot discloses dealings in Cannara Biotech Inc. (formerly, Dunbar Capital Corp.) to SEDI. The record holds 5 filings, for trades running from 31 December 2018 to 19 February 2020.

Purchases make up the whole of the open-market record (3 purchases, €171k). Unlike grants, an open-market purchase is paid for by the insider, at the market price.

In size, the median ticket on the buying side is €9,951. None of the 3 purchases we analysed coincided with buying by another insider of the same company within 30 days.

The latest filing, published on 20 February 2020, reports a transaction of €519k in Cannara Biotech Inc. (formerly, Dunbar Capital Corp.). The last insider purchase was made public on 15 August 2019, 2,627 days ago. Between a trade and the moment it shows up on SEDI, the median delay is 1 day. Until a filing is published, the market cannot know about the trade. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.